New Owner
Eli Lilly - CoLucid Pharmaceuticals
Eli Lilly acquires CoLucid Pharmaceuticals
Announced: January 18, 2017
Type: Acquisition
Disposition: Separate Entity
Terms: Cash
Status: Pending
Amount: $ 960,000,000
Acquisition News
Add News
Eli Lilly Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Apr 22, 2014 |
|
Undisclosed amount |
| Feb 24, 2014 |
|
Undisclosed amount |
| Jan 24, 2012 |
|
Undisclosed amount |
| Nov 08, 2010 |
|
$ 800,000,000 |
| Jul 02, 2010 |
|
$ 280,000,000 |
